CAS: 2260905-08-4

Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary

Tauro-α-muricholic acid sodium is a peptide that belongs to the group of activators. It is a high purity and ion channel inhibitor with low toxicity. The anti-inflammatory properties of tauro-α-muricholic acid sodium are due to its ability to inhibit the production of cytokines, including tumor necrosis factor (TNF)-α, IL-1β, IL-6, and IL-8. Tauro-α-muricholic acid sodium also inhibits the interactions between many proteins and receptors such as CD4, CD25, CD28, CD45RA, LFA1/CD11a, LFA2/CD18, ICAM1/CD54.